Additional Proxy Soliciting Materials (definitive) (defa14a)
March 17 2020 - 4:17PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
SCHEDULE
14A INFORMATION
Proxy
Statement Pursuant to Section 14(a) of the Securities Exchange Act
of 1934
Filed by the Registrant
☑
Filed by a Party
other than the Registrant ☐
Check the
appropriate box:
☐
Preliminary Proxy Statement
☐
Confidential, For Use of the Commission Only (As Permitted by Rule
14a-6(e)(2))
☐
Definitive Proxy Statement
☑
Definitive Additional Materials
☐
Soliciting Material under Rule 14a-12
CEL-SCI CORPORATION
|
(Name of Registrant as Specified In Its Charter)
|
|
(Name of Person(s) Filing Proxy Statement, if other than the
Registrant)
|
Payment of Filing
Fee (Check the appropriate box):
☑ No
fee required
☐ Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
(1) Title
of each class of securities to which transaction
applies:
(2) Aggregate
number of securities to which transaction applies:
(3) Per
unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the
amount on which the filing fee is calculated and state how it
was determined):
(4) Proposed
maximum aggregate value of transaction:
(5) Total
fee paid:
☐ Fee
paid previously with preliminary materials.
☐ Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by
registration statement number, or the form or schedule and the date
of its filing.
(1) Amount
Previously Paid:
(2) Form,
Schedule or Registration Statement No.:
(3) Filing
Party:
(4) Date
Filed:
At the
annual shareholders meeting scheduled for April 17, 2020
shareholders are being asked to approve the adoption of the
Company’s 2020 Non-Qualified Stock Option Plan. More
information about the plan follows:
Section
5 of the Plan provides that all Company employees, directors,
officers, and consultants and advisors are eligible to participate
in the Plan. However, the Company’s Compensation Committee,
which administers the Plan, determines which persons will be
granted options pursuant to the Plan and Section 5 of the Plan
restricts the type of services that can be provided in order for
consultants or advisors to be eligible to receive options pursuant
to the Plan. As of March 16, 2020 the Company had approximately 40
employees and three directors who are not employees of the Company.
The number of the Company’s consultants and advisors varies
from time to time.
The
Company’s Compensation Committee also determines, for each
option granted, the shares issuable upon the exercise of the
option, the option exercise price, the expiration date of the
option, any vesting requirements applicable to the option, and all
other terms of the option. The Company does not receive any cash or
property from the Optionee when an option is granted.
No
income is recognized by the Optionee at the time the option is
granted. The difference between the option price and the market
value of the shares on the date the option is exercised is taxable
as ordinary income to an Optionee at the time of exercise, and to
the extent such difference does not constitute unreasonable
compensation, is deductible by the Company at that time. Gain or
loss on any subsequent sale of shares received through the exercise
of an option is treated by the Optionee as a capital gain or
loss.
As of
March 16, 2020 the closing price of the Company’s common
stock was $9.15.
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Apr 2023 to Apr 2024